Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity

Journal of Medicinal Chemistry
A P KozikowskiP M Blumberg

Abstract

Protein kinase C (PKC) is a complex enzyme system comprised of at least 11 isozymes that serves to mediate numerous extracellular signals which generate lipid second messengers. The discovery of isozyme-selective activators and inhibitors (modulators) of PKC is crucial to ascertaining the role of the individual isozymes in physiological and pathophysiological processes and to manipulating their function. The discovery of such small molecule modulators of PKC is at present a largely unmet pharmacological need. Herein we detail our modeling studies which reveal how the natural product indolactam V (ILV) and its 8-membered ring analogue, the benzolactam 15, bind to the CRD2 activator domain of PKC. These modeling studies reveal that not all PKC ligands possess a common pharmacophore, and further suggest an important role of specific hydrophobic contacts in the PKC-ligand interaction. The modeling studies find strong experimental support from mutagenesis studies on PKC alpha that reveal the crucial role played by the residues proline 11, leucine 20, leucine 24, and glycine 27. Next, we describe the synthesis of two 8-substituted benzolactams starting from L-phenylalanine and characterize their isozyme selectivity; one of the two be...Continue Reading

References

Apr 13, 1979·Science·J H CardellinaR E Moore
Jan 1, 1991·Pharmacology & Therapeutics·S Stabel, P J Parker
Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A M Jeffrey, R M Liskamp
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P A WenderP M Blumberg
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A ItaiS Sakai

❮ Previous
Next ❯

Citations

Jul 26, 2005·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Kazuhiro IrieHajime Ohigashi
Feb 16, 2010·Aging Clinical and Experimental Research·Francesco PanzaAlberto Pilotto
Aug 26, 2000·European Journal of Medicinal Chemistry·G Eugene Kellogg, D J Abraham
Feb 24, 2001·Bioorganic & Medicinal Chemistry Letters·D MaP M Blumberg
Aug 28, 2003·Bioorganic & Medicinal Chemistry Letters·Yu NakagawaKen-ichiro Tsuda
Jun 9, 1999·Bioorganic & Medicinal Chemistry Letters·D MaP M Blumberg
Jan 15, 2000·Bioorganic & Medicinal Chemistry Letters·Y Endo, A Yokoyama
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·René EtcheberrigarayDaniel L Alkon
Feb 24, 2009·Trends in Biochemical Sciences·T J Nelson, D L Alkon
Aug 9, 2016·Organic Letters·Sandra M King, Stephen L Buchwald
Nov 7, 2014·Chemical Reviews·Joydip Das, Ghazi M Rahman
May 5, 2011·Chembiochem : a European Journal of Chemical Biology·Noemi KedeiPeter M Blumberg
Feb 4, 2012·Molecular BioSystems·Narsimha MamidiDebasis Manna
Feb 3, 2021·Advances in Biological Regulation·Sachin Katti, Tatyana I Igumenova
Aug 14, 2020·Journal of the American Chemical Society·Sachini U SiriwardenaAmit Choudhary
May 15, 2009·Journal of Medicinal Chemistry·Gustav Boije af GennäsJari Yli-Kauhaluoma
Dec 17, 2009·Journal of Natural Products·Minh U HuynhDaniel J Edwards
Jul 13, 2013·The Journal of Organic Chemistry·Michele MariGiovanni Piersanti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.